Intestinal Behçet's Disease with Primary Myelofibrosis Involving Trisomy 8

Taisuke Narazaki, Motoaki Shiratsuchi, Mariko Tsuda, Yasuhiro Tsukamoto, Hiroki Muta, Toru Masuda, Daisaku Kimura, Akiko Takamatsu, Ryota Nakanishi, Eiji Oki, Minako Fujiwara, Yoshinao Oda, Yasuhiro Nakashima, Yoshihiro Ogawa

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Behçet's disease (BD) is a disorder characterized by systemic inflammation of multiple organs, including the intestines. Several studies have reported a relationship between myelodysplastic syndrome and BD, and trisomy 8 was frequently seen, especially in intestinal BD. However, the association of BD with primary myelofibrosis (PMF) has not been well documented. A 58-year-old Japanese female was diagnosed with PMF in 2014. The symptoms of PMF resolved with ruxolitinib. However, she developed fever and intestinal perforation due to multiple ulcers in the terminal ileum in 2017. Intestinal perforation recurred 1 month later, and the dose of ruxolitinib was tapered. After discontinuation of ruxolitinib, she presented with recurrent oral aphthous ulcers and uveitis. Subsequently, intestinal perforation recurred, and she was diagnosed with intestinal BD. Trisomy 8 was identified in her peripheral blood. She underwent steroid therapy, azathioprine, and infliximab. This case suggests relationships between PMF, trisomy 8, and BD.

Original languageEnglish
Pages (from-to)253-256
Number of pages4
JournalActa Haematologica
Volume142
Issue number4
DOIs
Publication statusPublished - Nov 1 2019

Fingerprint

Intestinal Diseases
Primary Myelofibrosis
Intestinal Perforation
Oral Ulcer
Myelodysplastic Syndromes
Uveitis
Azathioprine
Ileum
Ulcer
Intestines
Fever
Steroids
Inflammation
Trisomy Chromosome 8
INCB018424
Therapeutics

All Science Journal Classification (ASJC) codes

  • Hematology

Cite this

Intestinal Behçet's Disease with Primary Myelofibrosis Involving Trisomy 8. / Narazaki, Taisuke; Shiratsuchi, Motoaki; Tsuda, Mariko; Tsukamoto, Yasuhiro; Muta, Hiroki; Masuda, Toru; Kimura, Daisaku; Takamatsu, Akiko; Nakanishi, Ryota; Oki, Eiji; Fujiwara, Minako; Oda, Yoshinao; Nakashima, Yasuhiro; Ogawa, Yoshihiro.

In: Acta Haematologica, Vol. 142, No. 4, 01.11.2019, p. 253-256.

Research output: Contribution to journalArticle

Narazaki, T, Shiratsuchi, M, Tsuda, M, Tsukamoto, Y, Muta, H, Masuda, T, Kimura, D, Takamatsu, A, Nakanishi, R, Oki, E, Fujiwara, M, Oda, Y, Nakashima, Y & Ogawa, Y 2019, 'Intestinal Behçet's Disease with Primary Myelofibrosis Involving Trisomy 8', Acta Haematologica, vol. 142, no. 4, pp. 253-256. https://doi.org/10.1159/000501019
Narazaki, Taisuke ; Shiratsuchi, Motoaki ; Tsuda, Mariko ; Tsukamoto, Yasuhiro ; Muta, Hiroki ; Masuda, Toru ; Kimura, Daisaku ; Takamatsu, Akiko ; Nakanishi, Ryota ; Oki, Eiji ; Fujiwara, Minako ; Oda, Yoshinao ; Nakashima, Yasuhiro ; Ogawa, Yoshihiro. / Intestinal Behçet's Disease with Primary Myelofibrosis Involving Trisomy 8. In: Acta Haematologica. 2019 ; Vol. 142, No. 4. pp. 253-256.
@article{a46ca2dd924544c2887bc375960ba81d,
title = "Intestinal Beh{\cc}et's Disease with Primary Myelofibrosis Involving Trisomy 8",
abstract = "Beh{\cc}et's disease (BD) is a disorder characterized by systemic inflammation of multiple organs, including the intestines. Several studies have reported a relationship between myelodysplastic syndrome and BD, and trisomy 8 was frequently seen, especially in intestinal BD. However, the association of BD with primary myelofibrosis (PMF) has not been well documented. A 58-year-old Japanese female was diagnosed with PMF in 2014. The symptoms of PMF resolved with ruxolitinib. However, she developed fever and intestinal perforation due to multiple ulcers in the terminal ileum in 2017. Intestinal perforation recurred 1 month later, and the dose of ruxolitinib was tapered. After discontinuation of ruxolitinib, she presented with recurrent oral aphthous ulcers and uveitis. Subsequently, intestinal perforation recurred, and she was diagnosed with intestinal BD. Trisomy 8 was identified in her peripheral blood. She underwent steroid therapy, azathioprine, and infliximab. This case suggests relationships between PMF, trisomy 8, and BD.",
author = "Taisuke Narazaki and Motoaki Shiratsuchi and Mariko Tsuda and Yasuhiro Tsukamoto and Hiroki Muta and Toru Masuda and Daisaku Kimura and Akiko Takamatsu and Ryota Nakanishi and Eiji Oki and Minako Fujiwara and Yoshinao Oda and Yasuhiro Nakashima and Yoshihiro Ogawa",
year = "2019",
month = "11",
day = "1",
doi = "10.1159/000501019",
language = "English",
volume = "142",
pages = "253--256",
journal = "Acta Haematologica",
issn = "0001-5792",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Intestinal Behçet's Disease with Primary Myelofibrosis Involving Trisomy 8

AU - Narazaki, Taisuke

AU - Shiratsuchi, Motoaki

AU - Tsuda, Mariko

AU - Tsukamoto, Yasuhiro

AU - Muta, Hiroki

AU - Masuda, Toru

AU - Kimura, Daisaku

AU - Takamatsu, Akiko

AU - Nakanishi, Ryota

AU - Oki, Eiji

AU - Fujiwara, Minako

AU - Oda, Yoshinao

AU - Nakashima, Yasuhiro

AU - Ogawa, Yoshihiro

PY - 2019/11/1

Y1 - 2019/11/1

N2 - Behçet's disease (BD) is a disorder characterized by systemic inflammation of multiple organs, including the intestines. Several studies have reported a relationship between myelodysplastic syndrome and BD, and trisomy 8 was frequently seen, especially in intestinal BD. However, the association of BD with primary myelofibrosis (PMF) has not been well documented. A 58-year-old Japanese female was diagnosed with PMF in 2014. The symptoms of PMF resolved with ruxolitinib. However, she developed fever and intestinal perforation due to multiple ulcers in the terminal ileum in 2017. Intestinal perforation recurred 1 month later, and the dose of ruxolitinib was tapered. After discontinuation of ruxolitinib, she presented with recurrent oral aphthous ulcers and uveitis. Subsequently, intestinal perforation recurred, and she was diagnosed with intestinal BD. Trisomy 8 was identified in her peripheral blood. She underwent steroid therapy, azathioprine, and infliximab. This case suggests relationships between PMF, trisomy 8, and BD.

AB - Behçet's disease (BD) is a disorder characterized by systemic inflammation of multiple organs, including the intestines. Several studies have reported a relationship between myelodysplastic syndrome and BD, and trisomy 8 was frequently seen, especially in intestinal BD. However, the association of BD with primary myelofibrosis (PMF) has not been well documented. A 58-year-old Japanese female was diagnosed with PMF in 2014. The symptoms of PMF resolved with ruxolitinib. However, she developed fever and intestinal perforation due to multiple ulcers in the terminal ileum in 2017. Intestinal perforation recurred 1 month later, and the dose of ruxolitinib was tapered. After discontinuation of ruxolitinib, she presented with recurrent oral aphthous ulcers and uveitis. Subsequently, intestinal perforation recurred, and she was diagnosed with intestinal BD. Trisomy 8 was identified in her peripheral blood. She underwent steroid therapy, azathioprine, and infliximab. This case suggests relationships between PMF, trisomy 8, and BD.

UR - http://www.scopus.com/inward/record.url?scp=85071579824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071579824&partnerID=8YFLogxK

U2 - 10.1159/000501019

DO - 10.1159/000501019

M3 - Article

C2 - 31291615

AN - SCOPUS:85071579824

VL - 142

SP - 253

EP - 256

JO - Acta Haematologica

JF - Acta Haematologica

SN - 0001-5792

IS - 4

ER -